Search

everythinglearnresearchcommunity

for

Search:↓

An elderly Chinese man lost all his hair after taking a new heart medication.

New guidelines stress early diagnosis and lifestyle changes to manage metabolic syndrome and prevent complications.

A 27-year-old with APS-1 showed improvement in symptoms after treatment.

Enzymes are classified into six types and are essential for many biological processes, with only a few targeted by drugs.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

Blocking cholesterol production may help control hair loss in Primary Cicatricial Alopecia by affecting key regulators.

Some blood pressure medications are linked to a higher risk of skin cancer.

Certain medications and patient factors increase the risk of Intraoperative Floppy Iris Syndrome during cataract surgery, but with careful planning and technique adjustments, complications can be minimized.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Some common medications like metformin, insulin, and ACE inhibitors can lower PSA levels, while statins don't, and low dose finasteride significantly reduces PSA.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Hormones significantly affect hair and oil gland function in the skin, and more research is needed on skin-related hormone disorders.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

Lisinopril, a heart medication, probably caused hair loss in a patient, which stopped after switching drugs.

Some blood thinners and blood pressure medicines can cause hair loss, which usually starts 1 to 6 months after beginning the medication.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Re-evaluating minoxidil, reducing sodium intake, and addressing arteriolar hypertrophy can improve hypertension management.

Women experience more side effects and have worse blood pressure control from hypertension treatments than men, despite using different medications.

Vasodilators may worsen abdominal aortic aneurysm.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Spironolactone might lower the chance of getting rosacea.

The model and estimator can predict drug exposure in kidney transplant patients well.

Objective assessment is needed to accurately determine medication use and adherence.